AMSTERDAM (MedPage Today) -- Aspirin's survival benefit in colon cancer correlated with the drug's antiplatelet activity but was not associated with a common tumor mutation or COX-2 expression, an analysis of 1,000 tumor samples showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment